res m glp 1 postbiotic Resbiotic resM Heat-Treated Probiotic Supplement for Metabolism & Gut Health, 30 Capsules GLP-1 Optimizer Bundle

30 A 505(b)(2) sponsor who can patent a more efficient or greener manufacturing process gains a significant cost advantage that functions as a secondary moat after the primary patents expire

Despite the ever-increasing popularity of GLP-1s for weight loss like Novo Nordisks Ozempic and Wegovy and Eli Lillys Mounjaro and Zepbound, its too soon to write off bariatric surgery as an option, some doctors say

To use the Medicare GLP-1 Bridge benefit, patients generally need to meet all of the following: Be enrolled in Medicare Part D (a standalone prescription drug plan or Medicare Advantage plan with prescription drug coverage) Be at least 18 years old AND meet one of three BMI-based eligibility tiers (more restrictive than the general FDA label): Tier 1: BMI of 35 or higher (no additional conditions required), or Tier 2: BMI of 30 or higher WITH heart failure with preserved ejection fraction, OR uncontrolled hypertension (systolic blood pressure above 140 mm Hg or diastolic above 90 mm Hg despite treatment with two antihypertensive medications), OR chronic kidney disease stage 3a or above, or Tier 3: BMI of 27 or higher WITH prediabetes (per American Diabetes Association guidelines), previous myocardial infarction, previous stroke, or symptomatic peripheral artery disease Be using the medication in combination with current and ongoing lifestyle modification including structured nutrition and physical activity Have a prescription from a qualified prescriber (any licensed clinician with prescribing authority can prescribe

Although this condition doesnt affect every GLP-1 user, recognizing the warning signs remains critical

This data supports claims raised in a growing number of lawsuits filed against manufacturers, including Novo Nordisk and Eli Lilly

The medication is typically prescribed for periods of 12 weeks or less because tolerance can develop and the stimulant effects carry cardiovascular risks with long-term use